Joeky Senders

18 Chapter 1 References 1. Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016. Neuro- Oncology. 2019 Nov 1;21(Supplement_5):v1–100. 2. Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M. Epidemiology and molecular pathology of glioma. Nature Clinical Practice Neurology. 2006 Sep;2(9):494–503. 3. Nayak L, Lee EQ, Wen PY. Epidemiology of Brain Metastases. Curr Oncol Rep. 2012 Feb 1;14(1):48–54. 4. neuro-oncologie [Internet]. [cited 2019 Jul 8]. Available from: https://www.iknl.nl/oncologische-zorg/ tumorteams/neuro-oncologie 5. Nederlandse Kankerregistratie [Internet]. [cited 2019 Jul 5]. Available from: https://www.cijfersoverkanker. nl/ 6. Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015. Neuro Oncol. 2018 Oct 1;20(suppl_4):iv1–86. 7. Weller M, van den Bent M, Hopkins K, Tonn JC, Stupp R, Falini A, et al. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. The Lancet Oncology. 2014 Aug 1;15(9):e395–403. 8. Weller M, van den Bent M, Tonn JC, Stupp R, Preusser M, Cohen-Jonathan-Moyal E, et al. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. The Lancet Oncology. 2017 Jun 1;18(6):e315–29. 9. Gorlia T, Bent MJ van den, Hegi ME, Mirimanoff RO, Weller M, Cairncross JG, et al. Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3. The Lancet Oncology. 2008 Jan 1;9(1):29–38. 10. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. New England Journal of Medicine. 2005 Mar 10;352(10):987–96. 11. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. The Lancet Oncology. 2009 May 1;10(5):459–66. 12. Davis FG, Dolecek TA, McCarthy BJ, Villano JL. Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data. Neuro Oncol. 2012 Sep 1;14(9):1171–7. 13. Stelzer KJ. Epidemiology and prognosis of brain metastases. Surg Neurol Int. 2013 May 2;4(Suppl 4):S192– 202. 14. Soffietti R, Abacioglu U, Baumert B, Combs SE, Kinhult S, Kros JM, et al. Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO). Neuro Oncol. 2017 Feb 1;19(2):162–74. 15. Ghahramani Z. Probabilistic machine learning and artificial intelligence. Nature. 2015 May 28;521(7553):452–9. 16. Bishop C. Pattern Recognition and Machine Learning [Internet]. New York: Springer-Verlag; 2006 [cited 2019 Mar 28]. (Information Science and Statistics). Available from: https://www.springer.com/in/ book/9780387310732 17. Jordan MI, Mitchell TM. Machine learning: Trends, perspectives, and prospects. Science. 2015 Jul 17;349(6245):255–60. 18. Beam AL, Kohane IS. Big Data and Machine Learning in Health Care. JAMA. 2018 Apr 3;319(13):1317–8.